Evidence-basedEditor-reviewedCited sourcesUpdated regularly
Skin Actives

Argireline

Also known as: Acetyl hexapeptide-8, Acetyl hexapeptide-3, Botox-in-a-jar peptide

The 'Botox in a jar' peptide — weakens muscle contraction for softening expression lines, with modest but real evidence.

  • By IngredientWiki Editorial Team
  • Fact-checked by IngredientWiki Editorial Team
  • Updated 2026-09-26
  • 2 min read

In short

Argireline is the trade name for acetyl hexapeptide-8, a six-amino-acid peptide that mimics part of the SNAP-25 protein required for nerve-to-muscle signaling at the neuromuscular junction. By occupying that site, it reduces muscle contraction — the same ultimate effect as botulinum toxin, achieved far more gently and superficially. Topical trials at 10% concentration show modest reduction in wrinkle depth around the eyes after 4 weeks of use, roughly a fraction of injectable Botox's effect. It is the anchor of 'Botox in a jar' marketing; the honest framing is that it is a subtle, non-invasive softening tool, not a substitute for injectables.

  • Acetyl hexapeptide-8 (trade name Argireline)
  • SNAP-25 mimic: reduces neuromuscular signaling
  • 10% topical trials: modest wrinkle-depth reduction in ~4 weeks
  • Effect is a fraction of injectable neurotoxins

What is Argireline?

Argireline is the peptide that made skincare marketing departments dream: a molecule that interferes with the muscle-contraction signal that carves expression lines — the mechanism behind Botox, bottled and sold in serum form. The science underneath is genuine: acetyl hexapeptide-8 really does bind the SNAP-25 complex and measurably reduce muscle activity. The reality check is magnitude. Where injectable neurotoxin silences a muscle for months, argireline nudges contraction downward, softening lines gradually over weeks. As a non-invasive complement to a routine, it earns its place; as a 'jar' replacement for injections, it overpromises.

Where it comes from

Natural sources

  • Synthetic hexapeptide (glutamate-glutamate-methionine-glutamine-arginine-arginine) with an acetyl cap
  • Designed to mimic the N-terminal domain of SNAP-25

How it's made

Sold as raw peptide solution (Argireline) and in finished serums at 5–10%.

What it does in products

  • Competitive inhibition of SNARE-complex assembly
  • Reduced muscle contraction amplitude
  • Softening of dynamic expression lines
  • Non-invasive alternative to injectable neurotoxins

Benefits

Expression-line softening

moderate evidence

Randomized trials with 10% argireline report ~20–30% reduction in periorbital wrinkle depth after 4 weeks, versus placebo.

Complement to injectables

emerging evidence

Anecdotal and small-study evidence suggests it may extend results between neurotoxin treatments; formal data are limited.

Non-invasive safety

strong evidence

Unlike injectables, topical argireline has essentially no systemic effects and minimal irritation at standard concentrations.

Side effects & safety

Mild irritation or redness (uncommon)Concentration-dependent; patch-test at 10%.

Safety considerations

  • No systemic absorption expected; topical use generally considered acceptable, though data are absent — consult if concerned.
  • None known.
  • Not for: Known peptide sensitivity (rare)

How it's used

In supplements

Not an oral ingredient.

In skincare

5–10% in serums; apply to expression areas (forehead, crow's feet) once or twice daily for 4+ weeks.

Regulatory status

  • Cosmetic peptide; no FDA drug claims permitted. 'Botox-like' marketing is prohibited for cosmetics.
  • INCI name on cosmetic labels: Acetyl Hexapeptide-8.
  • Assessed as safe in cosmetics at use concentrations.

Popular products containing Argireline

  • The Ordinary Argireline Solution 10% — The reference 10% productThe Ordinary · Skincare
  • Peter Thomas Roth Peptide 21 products — Peptide blends including hexapeptidesPeter Thomas Roth · Skincare
  • Peach & Lily / K-beauty peptide serums — Hexapeptide-containing formulationsPeach & Lily · Skincare

Product names and brands are shown for reference and belong to their respective owners.

The SNAP-25 mechanism

Muscle contraction requires SNARE proteins to dock neurotransmitter vesicles at the nerve terminal — and botulinum toxin works by cleaving SNAP-25, blocking that docking. Argireline is a peptide fragment mimicking SNAP-25's N-terminus; it competes for the docking complex, reducing vesicle fusion and weakening contraction. The parallel is real, but the potency differs by orders of magnitude, and argireline works only where it can penetrate — the skin's surface layers.

Expectation calibration

The strongest published trial (10% solution, 30 days) showed roughly 27% wrinkle-depth reduction around the eyes versus 0% for placebo. Injectable Botox trials report 60–80% improvement. Argireline's effect is visible, cumulative, and reversible on discontinuation — best framed as maintenance and softening, not transformation.

Frequently asked questions

Is Argireline really 'Botox in a jar'?

Mechanistically related, practically distant — it softens expression lines a fraction as much as injectables. It is a legitimate adjunct, not an equivalent.

How long before I see results?

Trials show measurable changes at 4 weeks with twice-daily use. Expect softening rather than erasure.

Can I use argireline with retinol and acids?

Generally yes — layer after water-based actives, before moisturizer. As with any peptide, avoid extreme pH in the same application.

The bottom line

Argireline is a scientifically grounded peptide with modest, real wrinkle-softening effects — the honest 'Botox in a jar' is a maintenance serum, not a needle replacement.

References

  1. Acetyl hexapeptide-8 in periorbital wrinkles: clinical study. International Journal of Cosmetic Science. https://pubmed.ncbi.nlm.nih.gov/12487405/
  2. Topical peptides in anti-aging: review. PubMed Central. https://pubmed.ncbi.nlm.nih.gov/32662149/
  3. SNARE complex and neurotoxin mechanisms. PubMed. https://pubmed.ncbi.nlm.nih.gov/29183497/